FBT vs. XBI
Compare and contrast key facts about First Trust Amex Biotechnology Index (FBT) and SPDR S&P Biotech ETF (XBI).
FBT and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FBT is a passively managed fund by First Trust that tracks the performance of the NYSE Arca Biotechnology Index. It was launched on Jun 23, 2006. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006. Both FBT and XBI are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBT or XBI.
Correlation
The correlation between FBT and XBI is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
FBT vs. XBI - Performance Comparison
Key characteristics
FBT:
0.61
XBI:
-0.12
FBT:
0.94
XBI:
0.02
FBT:
1.13
XBI:
1.00
FBT:
0.60
XBI:
-0.05
FBT:
2.54
XBI:
-0.30
FBT:
5.13%
XBI:
10.83%
FBT:
21.32%
XBI:
27.01%
FBT:
-40.51%
XBI:
-63.89%
FBT:
-11.93%
XBI:
-53.42%
Returns By Period
In the year-to-date period, FBT achieves a -3.46% return, which is significantly higher than XBI's -10.18% return. Over the past 10 years, FBT has outperformed XBI with an annualized return of 3.47%, while XBI has yielded a comparatively lower 1.11% annualized return.
FBT
-3.46%
-4.59%
-3.94%
11.15%
0.99%
3.47%
XBI
-10.18%
-7.11%
-16.82%
-3.49%
-3.50%
1.11%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBT vs. XBI - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than XBI's 0.35% expense ratio.
Risk-Adjusted Performance
FBT vs. XBI — Risk-Adjusted Performance Rank
FBT
XBI
FBT vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBT vs. XBI - Dividend Comparison
FBT's dividend yield for the trailing twelve months is around 0.73%, more than XBI's 0.17% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.73% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% | 0.05% |
XBI SPDR S&P Biotech ETF | 0.17% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
FBT vs. XBI - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for FBT and XBI. For additional features, visit the drawdowns tool.
Volatility
FBT vs. XBI - Volatility Comparison
The current volatility for First Trust Amex Biotechnology Index (FBT) is 13.67%, while SPDR S&P Biotech ETF (XBI) has a volatility of 15.26%. This indicates that FBT experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.